BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38482444)

  • 41. Development and validation of a nomogram for predicting survival in patients with non-metastatic primary adenocarcinoma of the bladder.
    Yu DD; Dong H; Chen WK; Chen K; Wu ZG; Li CD; Cai J; Xiao YB
    Transl Cancer Res; 2020 Sep; 9(9):5155-5165. PubMed ID: 35117882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis.
    Wang X; Xu Y; Xu J; Chen Y; Song C; Jiang G; Chen R; Mao W; Zheng M; Wan Y
    Transl Cancer Res; 2023 Apr; 12(4):804-827. PubMed ID: 37180650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer.
    Tian S; Sun S; Mao W; Qian S; Zhang L; Zhang G; Xu B; Chen M
    Int J Gen Med; 2021; 14():5091-5103. PubMed ID: 34511991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.
    Zhang Z; Zhanghuang C; Wang J; Tian X; Wu X; Li M; Mi T; Liu J; Jin L; Li M; He D
    Front Oncol; 2022; 12():918780. PubMed ID: 35814387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
    Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
    J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a prognostic nomogram for Hürthle cell thyroid carcinoma: a SEER-based study.
    Shen C; Zhao Y; Qiu X; Li P; Ding Y; Wang W; Sun B; Li X; Jiang W
    Gland Surg; 2022 Mar; 11(3):535-544. PubMed ID: 35402212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
    Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
    Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
    Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
    Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study.
    Sun Y; Li Z; Tian Y; Gao C; Liang B; Cao S; Liu X; Liu X; Meng C; Xu J; Yang H; Zhou Y
    BMC Gastroenterol; 2023 Apr; 23(1):117. PubMed ID: 37041468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and Validation of a Personalized Prognostic Prediction Model for Patients With Spinal Cord Astrocytoma.
    Yang S; Yang X; Wang H; Gu Y; Feng J; Qin X; Feng C; Li Y; Liu L; Fan G; Liao X; He S
    Front Med (Lausanne); 2021; 8():802471. PubMed ID: 35118095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database.
    Zhang X; Hu Y; Deng K; Ren W; Zhang J; Liu C; Ma B
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):14057-14070. PubMed ID: 37548772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gleason score, surgical and distant metastasis are associated with cancer-specific survival and overall survival in middle aged high-risk prostate cancer: A population-based study.
    Cao G; Li Y; Wang J; Wu X; Zhang Z; Zhanghuang C; Han K
    Front Public Health; 2022; 10():1028905. PubMed ID: 36330113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic nomogram for colorectal cancer patients with multi-organ metastases: a Surveillance, Epidemiology, and End Results program database analysis.
    Tang X; Hu N; Huang S; Jiang J; Rao H; Yang X; Yuan Y; Zhang Y; Xia G
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12131-12143. PubMed ID: 37428251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A web-based predictive model for overall survival of patients with cutaneous Merkel cell carcinoma: A population-based study.
    Xu W; Le Y; Zhang J
    Front Endocrinol (Lausanne); 2022; 13():1038181. PubMed ID: 36506062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.
    Gao B; Wang MD; Li Y; Huang F
    Front Public Health; 2022; 10():949500. PubMed ID: 35991065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
    Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
    Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
    Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
    Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical features and a prognostic nomogram based on the SEER database for hepatoblastoma, hepatocellular carcinoma, and embryonal sarcoma among children and adolescents.
    Ge B; Zhuo C; Tang Q; Wu Y
    Transl Pediatr; 2023 Feb; 12(2):172-184. PubMed ID: 36891371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma.
    Wang Z; Wang L; Hua Y; Zhuang X; Bai Y; Wang H
    Front Oncol; 2023; 13():1157057. PubMed ID: 37260969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.